American Regent Vasopressin Injection Recall: Subpotent Product Risk
American Regent recalls vasopressin injection vials due to subpotent product and impurities. This medication is for IV use only and requires immediate action.
Lower-risk recall
Subpotent product in addition to having out-of-specification results for impurities.
Contact the company
What happened, in plain English
American Regent is recalling vasopressin injection vials that may be subpotent and have impurities. This could affect medical treatment effectiveness and safety for patients using the product. Read more at govinfonow.com/recall/32680-american-regent-vasopressin-injection-recall-subpotent-product-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32680-american-regent-vasopressin-injection-recall-subpotent-product-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0507-2024
Cite this page
“American Regent Vasopressin Injection Recall: Subpotent Product Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32680-american-regent-vasopressin-injection-recall-subpotent-product-risk. Based on FDA recall #D-0507-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0507-2024%22&limit=1).
Why it’s dangerous
The product may be less potent than intended, which could lead to inadequate medical treatment. Impurities in the product might also pose safety risks during intravenous administration.
Who’s affected
Healthcare professionals who use this medication for intravenous infusion. Patients receiving treatment with this product may be at risk if the medication is not effective.
How to tell if you have this one
Check for the product name 'Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial' with NDC 0517-1030-01 and lot number 23061L1C0. The expiration date is January 31, 2025.
- Brand
American Regent- Category
Drug
What to do — step by step
Check Product Details
Verify the product name, NDC number, and lot number to confirm if it is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0507-2024 (May 13, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0507-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.